William Blair acted as the exclusive advisor to CentralReach LLC, (CentralReach) a portfolio company of Insight Partners (Insight), in connection with its pending acquisition by Roper Technologies, Inc. (NASDAQ: ROP) (Roper) for $1.85 billion. The transaction was announced on March 24, 2025, and marks William Blair’s 8th signed or closed M&A advisory deal in healthcare technology in 2025.

About the Companies

CentralReach is a leading provider of cloud-native software enabling the workflow and administration of Applied Behavior Analysis (ABA) therapy. Over 200,000 professionals utilize the company’s purpose-built solutions to help provide care for individuals with autism spectrum disorder (ASD) and related intellectual and developmental disabilities (IDD). ABA therapy providers rely on CentralReach’s comprehensive electronic medical records platform as their mission critical operating system, which includes highly specialized tools for client set-up, practice management, claims processing, care scheduling, clinical data collection, and service delivery, along with several AI-powered add-on modules.

Insight is a global software investor partnering with high-growth technology, software, and internet startup and scaleup companies that are driving transformative change in their industries. As of September 30, 2024, the firm has over $90 billion in regulatory assets under management. Insight has invested in more than 800 companies worldwide and has seen over 55 portfolio companies achieve an IPO. Based in New York City, Insight has offices in London, Tel Aviv, and the Bay Area. The firm’s mission is to find, fund, and work successfully with visionary executives, providing them with tailored, hands-on software expertise along their growth journey, from their first investment to IPO.

Roper is a constituent of the S&P 500 and Fortune 1000 and has a proven, long-term track record of compounding cash flow and shareholder value. The company operates market leading businesses that design and develop vertical software and technology-enabled products for a variety of defensible niche markets. Roper utilizes a disciplined, analytical, and process-driven approach to redeploy its excess capital toward high-quality acquisitions.

Learn more about our healthcare IT investment banking expertise.